2024 Speaker Faculty

Aarron Willingham

Executive Director

Merck & Co

Anna Galkin

Chief Scientific Officer

Axelia Oncology

Carman Giacomantonio, STING & TLR-Targeted Therapies Summit

Carman Giacomantonio

Professor of Surgery

Dalhousie University

Dae-Shik Kim

Sr. Principal Scientist

Eisai

Dinesh Chandra

AD

Independent Consultant

Diwakar Davar

AP

University of Pittsburgh Medical Center

Elena Bekerman

Sr Research Scientist

Gilead Sciences

Hong Wan

President, Chief Executive Officer & Co-Founder

Tallac Therapeutics

James Appleman

Co- Founder, Chief Scientific Officer, Senior Vice- President & Director - Research & Development

Primmune Therapeutics, Inc.

Kader Thiam, STING & TLR-Targeted Therapies Summit

Kader Thiam

Senior Vice President Discovery, Preclinical Models, and Services

GenOway

Kathleen McGuire

Principal Scientist

Abbvie

Laughing Bear Torrez, STING & TLR-Targeted Therapies Summit

Laughing Bear Torrez

Senior Scientist

Bolt Biotherapeutics

Lei Jin

Associate Professor (tenured)

University of Florida

Michael Newman

Founder & Chief Scientific Officer

Indaptus Therapeutics

Paul Song

Chief Scientific Officer

Genequantum Healthcare

Richard Johnson

Vice President - Development

Saros Therapeutics

Roy Baynes

Executive Vice President & Chief Medical Officer

Eikon Therapeutics

Scott Pesiridis

Scientific Director and GSK Fellow

GlaxoSmithKline Plc

Stephen Webber, STING & TLR-Targeted Therapies Summit

Stephen Webber

Vice President, Medicinal Chemistry & Co-founder

Primmune Therapeutics

Steven Katz

Chief Medical Officer

TriSalus Life Sciences

Tony Zhang

Co-founder & Chief Executive Officer

Tyligand

Yaara Ofir-Rosenfeld

Director, Translational Oncology

STORM Therapeutics Ltd.

FULL EVENT GUIDE
PARTNER
REGISTER INTEREST